Lopez, J. S., Haefliger, S., Plummer, R., Clement, P. M., Laubli, H. P., Roth, P., … Steinbach, J. (2023). Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Lopez, Juanita Suzanne, Simon Haefliger, Ruth Plummer, Paul M. Clement, Heinz Philipp Laubli, Patrick Roth, TR Jeffry Evans, et al. “Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Lopez JS, Haefliger S, Plummer R, Clement PM, Laubli HP, Roth P, et al. Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Lopez, Juanita Suzanne, et al. “Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Lopez JS, Haefliger S, Plummer R, Clement PM, Laubli HP, Roth P, Evans TRJ, Brazil L, Tabatabai G, Wick A, Yau WHH, Wunderlich B, Beebe K, Eisner JR, Engelhardt M, Kaindl T, Lane HA, Hau P, Hundsberger T, Steinbach J. Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers. JOURNAL OF CLINICAL ONCOLOGY. 2023.